| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/24/2008 | EP1971574A2 Bicyclic heterocyclic compounds as antiinflammatory or antiallergic agents |
| 09/24/2008 | EP1971572A1 Cyclic amine derivatives and their uses |
| 09/24/2008 | EP1971570A2 Process for the preparation of metoprolol and its salts |
| 09/24/2008 | EP1971401A2 METHODS OF USING THE CALCINEURIN A VARIANT Cnaß1 |
| 09/24/2008 | EP1971371A2 Cancer therapies and pharmaceutical compositions used therein |
| 09/24/2008 | EP1971370A1 Oral s-adenosylmethionine compositions |
| 09/24/2008 | EP1971369A2 Combination of anticholinergics, glucocorticoids, beta2-agonists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases |
| 09/24/2008 | EP1971368A2 Compositions and methods for treating thrombocytopenia |
| 09/24/2008 | EP1971363A1 Combination treatments with gastrin agonists for diabetes and related diseases |
| 09/24/2008 | EP1971358A1 A method of treatment |
| 09/24/2008 | EP1971356A2 Inhibition of cxcr4 and/or cell motility by phenylalanine, cysteine or peptides containing said aminoacids |
| 09/24/2008 | EP1971354A1 Composition comprising liquiritigenin for preventing and treating liver disease |
| 09/24/2008 | EP1971349A2 Methods and systems for the delivery of corticosteroids having an increased lung deposition |
| 09/24/2008 | EP1971348A2 Systems and methods for the delivery of corticosteroids having an increased lung deposition |
| 09/24/2008 | EP1971347A2 Methods and systems for the delivery of corticosteroids |
| 09/24/2008 | EP1971346A2 Systems and methods for the delivery of corticosteroids |
| 09/24/2008 | EP1971345A2 Method and system for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| 09/24/2008 | EP1971344A1 A method of treating an acute vascular disorder |
| 09/24/2008 | EP1971343A2 Treatment of substance abuse |
| 09/24/2008 | EP1971342A1 Uses of rifamycins |
| 09/24/2008 | EP1971341A1 Use of morpholino compounds for the treatment of halitosis |
| 09/24/2008 | EP1971340A2 Nitric oxide enhancing pyruvate compounds, compositions and methods of use |
| 09/24/2008 | EP1971339A2 Combination of triazine derivatives and insulin secretion stimulators |
| 09/24/2008 | EP1971338A2 Combination of zd6474 and pemetrexed |
| 09/24/2008 | EP1971337A1 Serotonergic agents for treating sexual dysfunction |
| 09/24/2008 | EP1971336A2 Thrombin receptor antagonists as phophylaxis to complications from cardiopulmonary surgery |
| 09/24/2008 | EP1971335A2 Use of cns penetrating anticancer compounds for the treatment of protozan diseases |
| 09/24/2008 | EP1971334A2 Combination of ache inhibitor and 5-ht6 antagonist for the treatment of cognitive dysfunction |
| 09/24/2008 | EP1971333A2 Amino acid derivatives of indolinone based protein kinase inhibitors |
| 09/24/2008 | EP1971332A1 Use of tiotropium salts in the treatment of moderate persistent asthma |
| 09/24/2008 | EP1971331A2 4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders |
| 09/24/2008 | EP1971330A2 Combination of triazine derivatives and insulin sensitisers |
| 09/24/2008 | EP1971329A2 Use of triazine derivatives for the manufacture of a medicament having a cicatrising or angiogenic effect |
| 09/24/2008 | EP1971328A1 Transdermal therapeutic system for volatile and/or thermolabile substances |
| 09/24/2008 | EP1971327A2 Pharmaceutical compositions of ilaprazole |
| 09/24/2008 | EP1971324A1 Pharmaceutical composition for the treatment of nail diseases |
| 09/24/2008 | EP1971230A2 Treatment of stressed patients |
| 09/24/2008 | EP1971228A1 Natural high-potency sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses |
| 09/24/2008 | EP1906950A4 Ansamycin formulations and methods of use thereof |
| 09/24/2008 | EP1885725B1 Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents |
| 09/24/2008 | EP1865938A4 Dosing regimes for trans-clomiphene |
| 09/24/2008 | EP1831152B1 Tetralin and indane derivatives and uses thereof as 5-ht antagonists |
| 09/24/2008 | EP1814879B1 Derivatives of 4,7-dioxobenzothiazole-2-carboxamides, preparation method thereof and therapeutic uses of same |
| 09/24/2008 | EP1799227A4 Therapeutic agents targeting the nc ca-atp channel and methods of use thereof |
| 09/24/2008 | EP1723116B1 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors |
| 09/24/2008 | EP1696922B1 Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases |
| 09/24/2008 | EP1682012A4 Composition and apparatus for transdermal delivery |
| 09/24/2008 | EP1677779B1 Combination of an antagonist of the tp-receptors and clopidogrel |
| 09/24/2008 | EP1677776B1 Extended release tablet formulations of venlafaxine |
| 09/24/2008 | EP1653964B1 Cancer combination therapy comprising azd2171 and zd1839 |
| 09/24/2008 | EP1648468B1 Active substance combination comprising a compound with npy receptor affinity and a compound with 5-ht6 receptor affinity |
| 09/24/2008 | EP1646373B1 Orodispersible pharmaceutical composition of an antithrombotic compound |
| 09/24/2008 | EP1631155B1 Method for producing a chitosan containing salt having a function of lowering blood pressure |
| 09/24/2008 | EP1594833B1 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
| 09/24/2008 | EP1585509B1 Sphingolipids for improvement of the composition of the intestinal flora |
| 09/24/2008 | EP1572299B1 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 09/24/2008 | EP1537096B1 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 09/24/2008 | EP1513520B1 Substituted pyrrolines as kinase inhibitors |
| 09/24/2008 | EP1509528B1 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/24/2008 | EP1496836B1 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors |
| 09/24/2008 | EP1476081A4 Method and process for producing youthful-appearing, small-pored, and smooth skin |
| 09/24/2008 | EP1465877B1 Positive-working photoimageable bottom antireflective coating |
| 09/24/2008 | EP1438031B1 Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer |
| 09/24/2008 | EP1408986B1 Proteomimetic compounds and methods |
| 09/24/2008 | EP1404291B1 Water-free ubiquinone concentrate |
| 09/24/2008 | EP1383578B1 Single dose aromatase inhibitor for treating infertility |
| 09/24/2008 | EP1381599B1 Quinazoline derivatives |
| 09/24/2008 | EP1372617B1 Gastroresistant salts of ketoacids and amino acids and their use for preparing medicines |
| 09/24/2008 | EP1365762B1 Method for increasing leptin levels using nicotinic acid compounds |
| 09/24/2008 | EP1341535B1 Skin whiteners containing hydroxytetronic acid |
| 09/24/2008 | EP1322650B1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
| 09/24/2008 | EP1292315B1 Use of sulodexide for the treatment of diabetic nephropathy |
| 09/24/2008 | EP1276462B1 Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| 09/24/2008 | EP1254658B1 Remedies for the treatment of nerve diorders |
| 09/24/2008 | EP1066016B2 Poly-aminoacid derivatives and their use in compositions for treating keratinous fibres |
| 09/24/2008 | EP1027040B1 Use of mitoguazone dihydrochloride for treating macrophage-associated diseases |
| 09/24/2008 | CN201120000Y Traditional Chinese medicine permeation plaster |
| 09/24/2008 | CN101273130A Nucleic acid agents for downregulating H19, and methods of using same |
| 09/24/2008 | CN101273052A Macrocyclic inhibitors of hepatitis C virus |
| 09/24/2008 | CN101273051A Polymeric oligonucleotide prodrugs |
| 09/24/2008 | CN101273047A Thieno[2,3-B]pyridine-5-carbonitriles as protein kinase inhibitors |
| 09/24/2008 | CN101273046A Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists |
| 09/24/2008 | CN101273045A 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7h-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-c]-pyrimidin-5-amine |
| 09/24/2008 | CN101273043A Pyrazolo[1,5-alpha]pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists |
| 09/24/2008 | CN101273042A Macrocyclic inhibitors of hepatitis C virus |
| 09/24/2008 | CN101273040A Oxadiazolyl pyrazolo-pyrimidines as MGLUR2 antagonists |
| 09/24/2008 | CN101273039A Heterobicyclic compounds useful as p38 kinase inhibiting agents |
| 09/24/2008 | CN101273038A Macrocylic inhibitors of hepatitis C virus |
| 09/24/2008 | CN101273037A New compounds for the treatment of neurological, psychiatric or pain disorders |
| 09/24/2008 | CN101273036A Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| 09/24/2008 | CN101273035A Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/24/2008 | CN101273034A Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/24/2008 | CN101273033A 4- (iH-indazol-s-yl-amino)-quinazoline compounds as ERBB receptor tyrosine kinase inhibitors for the treatment of cancer |
| 09/24/2008 | CN101273032A Pyrazine kinase inhibitors |
| 09/24/2008 | CN101273031A Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders |
| 09/24/2008 | CN101273030A Macrocyclic inhibitors of hepatitis C virus |
| 09/24/2008 | CN101273028A Macrocyclic inhibitors of hepatitis C virus |
| 09/24/2008 | CN101273027A Macrocyclic inhibitors of hepatitis C virus |
| 09/24/2008 | CN101273026A Indane derivatives as MCH receptor antagonists |
| 09/24/2008 | CN101273023A 5-substituted thiazol-2-yl amino compounds and compositions as protein kinase inhibitors |